Evidence map›Paper›PMID 42014996›Full record

ArticleBMC cardiovascular disorders2026

Left atrial strain compared to volume in long-term flecainide treated patients with atrial fibrillation - a retrospective cohort study.

Alexander Siotis, Pyotr G Platonov, Bjarne Madsen Hardig

Abstract readComparative Study
In one paragraph

Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alexander SiotisClinical Sciences Helsingborg, Department of Clinical Sciences Lund, Lund University, Svartbrödragränden 3, Helsingborg, 251 87, Sweden. alexander.siotis@med.lu.se.ORCID http://orcid.org/0000-0003-3351-7404
Pyotr G PlatonovDepartment of Cardiology, Clinical Sciences Lund, Lund University, Lund, 221 85, Sweden.
Bjarne Madsen HardigClinical Sciences Helsingborg, Department of Clinical Sciences Lund, Lund University, Svartbrödragränden 3, Helsingborg, 251 87, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeft atrial volume index (LAVI) is associated with recurrent atrial fibrillation (AF) during flecainide treatment. Nevertheless, AF patients with normal LAVI experience rhythm control failure. Our study sought to compare the association between left atrial strain and LAVI with rhythm control failure, in flecainide treated patients with AF.

methodsThis retrospective cohort study included consecutive patients ≥ 18 years of age with AF who were discharged after in-hospital initiation of flecainide. Patients without an echocardiogram in sinus rhythm within one year of initiation of flecainide were excluded. The primary endpoint was discontinuations due to rhythm control failure. Receiver operating characteristics determined optimal cutoffs for reservoir (LASr), conduit (LAScd) and contractile (LASct) left atrial longitudinal strains for the primary endpoint. These cutoffs were analysed using Cox regression, with 95% confidence intervals.

resultsSeventy patients were followed for a mean of 1.71 ± 1.56 years (mean age 59.4 ± 11.5 years; 66% male; 8.6% had persistent AF). The area under the curve for LASr was 0.764 (0.595–0.933), for LAScd 0.784 (0.634–0.934), and for LAVI 0.497 (0.345–0.795). Optimal cutoffs for LASr were < 23% and LAScd < 14.5%. These cutoffs had similar specificity (LASr 85% and LAScd 73%) but higher sensitivity (70% and 90%, respectively) compared to ≥moderately increased LAVI (84% and 36%) for the primary endpoint. Hazard ratios for LASr < 23% and LAScd < 14.5% were 9.09 (2.34–35.3) and 18.3 (2.31–145), respectively.

conclusionsImpaired left atrial strain was associated, independently from LAVI, with discontinuations due to rhythm control failure in patients receiving long-term flecainide treatment for AF.

Indexed as

Anti-Arrhythmia AgentsAtrial FibrillationAtrial Function, LeftFlecainideHeart AtriaHeart RateAgedFemaleHumansMaleMiddle AgedPredictive Value of TestsRecurrenceRetrospective StudiesRisk FactorsTime FactorsAnti-Arrhythmia AgentsFlecainideAtrial fibrillationEchocardiographyEfficacyFlecainideLeft atrial longitudinal strainRhythm control

Identifiers

PMID42014996
PMCPMC13101192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.